| Stage | FANG | % of rev | LHX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.6B | 100.00% | $6.1B | 100.00% | LHX ×1.09 |
| Gross profit | $4.7B | 84.84% | $1.6B | 26.60% | FANG +58.2pp |
| Operating income | $2.5B | 45.16% | $786M | 12.97% | FANG +32.2pp |
| Pre-tax income | $2.6B | 47.38% | $743M | 12.26% | FANG +35.1pp |
| Net income | $2.1B | 36.95% | $632M | 10.43% | FANG +26.5pp |
| Stage | FANG | LHX | Gap · A − B |
|---|---|---|---|
| Revenue | $5.6B100.00% | $6.1B100.00% | LHX ×1.09 |
| Gross profit | 84.84%$4.7B | 26.60%$1.6B | FANG +58.2pp |
| Operating income | 45.16%$2.5B | 12.97%$786M | FANG +32.2pp |
| Pre-tax income | 47.38%$2.6B | 12.26%$743M | FANG +35.1pp |
| Net income |
| 36.95%$2.1B |
| 10.43%$632M |
| FANG +26.5pp |
No shared counterparties.